


Cell X Technologies
Biotechnology Research • Cleveland, Ohio, United States • 11-20 Employees
Company overview
| Headquarters | 10000 Cedar Ave, Cleveland, Ohio 44106, US |
| Phone number | +12162024360 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Research, Life Sciences, Drug Screening, Medical Devices, Bioengineering, Biopharmaceuticals, Bioinformatics, Microscopy, Image Analysis, Regenerative Medicine, Stem Cells, Biomedical Engineering, Tissue Engineering, Cell Culture, Tissue Culture, Induced Pluripotent Stem Cells, Mammalian Cell Culture, Cell Biology, Adult Stem Cells, Mesenchymal Stem Cells, Cell Imaging |
| Founded | 2019 |
| Employees | 11-20 |
| Socials |
Key Contact at Cell X Technologies
Tom Londo
Board Of Directors Member
Cell X Technologies Email Formats
Cell X Technologies uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@cellxtechnologies.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@cellxtechnologies.com | 80% |
{first name}{last name} | johndoe@cellxtechnologies.com | 20% |
About Cell X Technologies
Cell X is pioneering a revolution in cell processing. At the core of this revolution lies our transformative Celligent platform – an innovative bundling of automation, imaging, data analytics, and machine learning that enables therapeutic researchers to develop consistent, reproducible, and scalable GMP-compliant processes for stem cells and bio-fabrication. Celligent enables the development of safe and effective products by executing the necessary process development and cell manufacturing procedures in a fully documented, compliant way. Successful cellular therapies demand starting with optimized cell sources; and intrinsic variability and heterogeneity among cell sources presents a major challenge. This critical first step of control over starting materials demands the use of quantitative and reproducible standards for cell and clone selection and process management based on critical process parameters (CPPs) in order to achieve products with defined critical quality attributes (CQAs). Backed by a highly experienced team, Cell X automates cell processing in diverse cell culture applications spanning mesenchymal stromal/stem cells (MSCs) and exosomes, induced pluripotent stem cells (iPSCs), hematopoietic stem cells (HSCs), connective tissue progenitor cells (CTPs) and tumor-infiltrating lymphocytes (TILs) as well as other progenitor cell types. We are dedicated to advancing the promise of cellular therapies for innovators and patients alike, ultimately making cell therapies more accessible to millions of patients worldwide.
Cell X Technologies revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | $6,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Cell X Technologies has 4 employees across 2 departments.
Departments
Number of employees
Funding Data
Explore Cell X Technologies's funding history, including investment rounds, total capital raised, and key backers.
Cell X Technologies Tech Stack
Discover the technologies and tools that power Cell X Technologies's digital infrastructure, from frameworks to analytics platforms.
Security
Security
Video players
JavaScript libraries
JavaScript libraries
JavaScript libraries
CDN
Font scripts
Miscellaneous
Programming languages
Blogs
CDN
Frequently asked questions
4.8
40,000 users



